Cellectis (CLLS) Net Income towards Common Stockholders (2016 - 2023)
Historic Net Income towards Common Stockholders for Cellectis (CLLS) over the last 9 years, with Q3 2023 value amounting to -$17.5 million.
- Cellectis' Net Income towards Common Stockholders rose 3858.85% to -$17.5 million in Q3 2023 from the same period last year, while for Dec 2023 it was -$59.3 million, marking a year-over-year increase of 2016.09%. This contributed to the annual value of -$106.1 million for FY2022, which is 20716.84% down from last year.
- As of Q3 2023, Cellectis' Net Income towards Common Stockholders stood at -$17.5 million, which was up 3858.85% from -$11.7 million recorded in Q2 2023.
- Cellectis' 5-year Net Income towards Common Stockholders high stood at $20.1 million for Q1 2020, and its period low was -$40.6 million during Q4 2020.
- In the last 5 years, Cellectis' Net Income towards Common Stockholders had a median value of -$28.5 million in 2022 and averaged -$23.8 million.
- Its Net Income towards Common Stockholders has fluctuated over the past 5 years, first plummeted by 36095.64% in 2019, then skyrocketed by 23169.6% in 2020.
- Cellectis' Net Income towards Common Stockholders (Quarter) stood at -$37.2 million in 2019, then decreased by 9.13% to -$40.6 million in 2020, then skyrocketed by 80.12% to -$8.1 million in 2021, then plummeted by 232.16% to -$26.8 million in 2022, then soared by 34.81% to -$17.5 million in 2023.
- Its last three reported values are -$17.5 million in Q3 2023, -$11.7 million for Q2 2023, and -$30.1 million during Q1 2023.